Table 3 Laboratory features of controlled and uncontrolled diabetic patients
From: Predictors of COVID-19 outcome in type 2 diabetes mellitus: a hospital-based study
Variables | Controlled diabetes (HBA1c < 7) N = 12 | Uncontrolled diabetes (HBA1c ≥ 7) N = 33 | Test of significance Mann*Whitney test | p value |
|---|---|---|---|---|
AST (IU/L): Median Min-max | 40 18–84 | 33 14–70 | 118 | 0.04* |
ALT (IU/L): Median Min- max | 38 16–60 | 30 15–62 | 161.5 | 0.34 |
D. Dimer: Median Min-max | .900 3.4.5 | .800 0.1–6.5 | 195 | 0.94 |
S. ferritin: Median Min-max | 365.5 190–850 | 350 15–1169 | 190 | 0.83 |
HB(g/dl): Median Min-max | 10.5 6.4–15 | 11.1 7–15.4 | 172 | 0.50 |
WBCs: Median Min-max | 7.55 2.4–12 | 11 5.1–21.3 | 94.5 | 0.008** |
Neutrophils: Median Min-max | 5.25 1.6–8.7 | 8.8 3.7–18.4 | 75 | 0.002** |
Lymphocytes: Median Min-max | 1.00 0.2–3.7 | 1.1 0.3–3.5 | 192.5 | 0.88 |
Platelets: Median Min-max | 207 96–286 | 210 81–452 | 173 | 0.52 |
ESR: Median Min-max | 59.5 12–88 | 75 22–130 | 102 | 0.01* |
CRP: Median Min-max | 29 6–96 | 38 11–250 | 157.5 | 0.29 |
LDH: Median Min-max | 345 100–520 | 400 29–870 | 178 | 0.60 |
BUN: Median Min-max | 135 40–310 | 57 20–244 | 126 | 0.06 |
Creatinine: Median Min-max | 1.85 0.9–9 | 1.4 0.5–10.5 | 169.5 | 0.46 |